(Press-News.org) St. Jude Children’s Research Hospital today announced M. Madan Babu, PhD, FRS, as the institution’s first Chief Data Scientist, Senior Vice President for Data Science, and leader of the newly formed Office of Data Science. This $195 million research enterprise will have 115 new positions.
In his new role, Babu will bring new, advanced computing technologies and data science approaches to biomedical research. His team will also facilitate the integration of biological and biomedical data, foster a data science research culture, and build international collaborations.
“Our ability to quickly analyze huge datasets is becoming increasingly crucial to scientific breakthroughs, particularly when it comes to biochemistry and cell biology,” said James R. Downing, MD, president and CEO of St. Jude. “Under the leadership of Dr. Babu, a globally recognized expert in this field, our Office of Data Science will strengthen data-sharing between the lab and the clinic, accelerating our progress in finding cures and developing treatments for children with catastrophic diseases.”
“Dr. Babu is a pioneer in developing and applying data science-based approaches to reveal fundamental principles of biological systems,” said J. Paul Taylor MD, PhD, executive vice president and scientific director. “Through this initiative, we aim to create a seamless scientific ecosystem where experimental, clinical and data scientists collaborate effectively to advance our understanding of healthy and disease states.”
The expanding role of data science in biomedical research
St. Jude accelerated its journey into data science with genomic studies and their associated molecular and clinical data, providing data and analysis resources to the global research community. Today, there are an estimated 150 petabytes of biological data from open sources. The explosion of different types of data in recent years such as imaging, structural, chemical, and population data has increased both the complexity and sheer amount of biological information available to scientists who need to translate the data into findings and then cures. The challenge is to integrate and derive actionable information from these large and diverse datasets.
“St. Jude is a unique place and I am honored to lead this initiative,” Babu said. “With our intellectual ecosystem of talented clinical, experimental and data scientists united under the same mission, there’s no better place than St. Jude to build a data science enterprise of this magnitude.”
Babu joined St. Jude in the Structural Biology department in 2020, following a 14-year tenure as a program leader at the MRC Laboratory of Molecular Biology in Cambridge, England. He is a recipient of the Gold Medal from the European Molecular Biology Organization and a recent inductee of the Academy of Medical Sciences and the Royal Society of London. He has made major contributions in the fields of G-protein coupled receptors, intrinsically disordered proteins and gene regulation.
Babu earned his PhD in computational genomics from Cambridge University and his undergraduate degree from Anna University, Chennai, India. Babu completed a postdoctoral fellowship at the National Institutes of Health, Bethesda, Maryland.
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease, and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress, a digital magazine and follow St. Jude on social media @stjuderesearch.
END
St. Jude names M. Madan Babu, PhD, senior vice president and chief data scientist
He will lead new $195 million data science enterprise for biologic discovery to advance pediatric medicine
2024-10-01
ELSE PRESS RELEASES FROM THIS DATE:
It all adds up: Study finds forever chemicals are more toxic as mixtures
2024-10-01
BUFFALO, N.Y. — A first-of-its-kind study has measured the toxicity of several types of per- and polyfluoroalkyl substances (PFAS), better known as “forever chemicals,” when mixed together in the environment and in the human body.
The good news: Most of the tested chemicals’ individual cytotoxicity and neurotoxicity levels were relatively low.
The bad news: the chemicals acted together to make the entire mixture toxic.
“Though they are structurally similar, not all forever chemicals are ...
SwRI-led team discovers carbon dioxide and hydrogen peroxide on Pluto’s moon Charon
2024-10-01
SAN ANTONIO — October 1, 2024 — A Southwest Research Institute-led team has detected carbon dioxide and hydrogen peroxide for the first time on the frozen surface of Pluto’s largest moon, Charon, using observations from the James Webb Space Telescope. These discoveries add to Charon’s known chemical inventory, previously identified by ground- and space-based observations, that includes water ice, ammonia-bearing species and the organic materials responsible for Charon’s gray and red coloration.
“Charon is the only midsized Kuiper Belt object, in the range of 300 to 1,000 miles in diameter, that has been geologically mapped, thanks ...
More clarity on hereditary colorectal cancer
2024-10-01
The genetic confirmation of a suspected diagnosis of "hereditary colorectal cancer" is of great importance for the medical care of affected families. However, many of the variants identified in the known genes cannot yet be reliably classified in terms of their causal role in tumor formation. Under the leadership of the University Hospital Bonn (UKB) and the University of Bonn, an international team of researchers has reassessed the medical relevance of a significant number of unclear variants and thus significantly ...
FOXM1 and PD-L1 in CDK4/6-MEK resistance in nerve tumors
2024-10-01
“We suggest that future therapeutic strategies targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 represent exciting future treatment options for MPNST patients.”
BUFFALO, NY- October 1, 2024 – A new mini review was published in Oncotarget's Volume 15 on September 30, 2024, entitled, “Linking FOXM1 and PD-L1 to CDK4/6-MEK targeted therapy resistance in malignant peripheral nerve sheath tumors.”
As highlighted in the abstract of this paper, malignant peripheral nerve sheath tumors (MPNSTs) are aggressive, Ras-driven sarcomas characterized ...
McMaster University researchers identify new therapeutic approach to preventing cancer from spreading to the brain
2024-10-01
Researchers at McMaster University have identified a new therapeutic approach to preventing cancer from spreading to the brain.
In a new study, published recently in the journal Cell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerability in metastatic brain cancer, which they say can be exploited with new drugs to prevent spread.
Singh, a professor in McMaster’s Department of Surgery and director of the Centre for Discovery in Cancer Research, says brain metastases are becoming increasingly prevalent and are extremely fatal, with 90 per cent of patients dying within one ...
Squid-inspired fabric for temperature-controlled clothing
2024-10-01
WASHINGTON, October 1, 2024 – Too warm with a jacket on but too cold without it? Athletic apparel brands boast temperature-controlling fabrics that adapt to every climate with lightweight but warm products. Yet, consider a fabric that you can adjust to fit your specific temperature needs.
Inspired by the dynamic color-changing properties of squid skin, researchers from the University of California, Irvine developed a method to manufacture a heat-adjusting material that is breathable and washable and can be integrated into flexible fabric. They published their ...
Using antimatter to detect nuclear radiation
2024-10-01
WASHINGTON, Oct. 1, 2024 – Nuclear fission reactors act as a key power source for many parts of the world and worldwide power capacity is expected to nearly double by 2050. One issue, however, is the difficulty of discerning whether a nuclear reactor is being used to also create material for nuclear weapons. Capturing and analyzing antimatter particles has shown promise for monitoring what specific reactor operations are occurring, even from hundreds of miles away.
In AIP Advances, by AIP Publishing, researchers from the University of Sheffield and the University of Hawaii developed ...
Modeling the minutia of motor manipulation with AI
2024-10-01
In neuroscience and biomedical engineering, accurately modeling the complex movements of the human hand has long been a significant challenge. Current models often struggle to capture the intricate interplay between the brain's motor commands and the physical actions of muscles and tendons. This gap not only hinders scientific progress but also limits the development of effective neuroprosthetics aimed at restoring hand function for those with limb loss or paralysis.
EPFL professor Alexander Mathis and his team have developed an AI-driven approach that ...
Survival gap eliminated for Black cord blood recipients with blood cancers, study finds
2024-10-01
Patients who receive umbilical cord blood transplants for blood cancers now live equally long regardless of their race, new research from UVA Cancer Center shows.
The findings, from UVA Health’s Karen Ballen, MD, and collaborators, suggests that a previously identified survival gap for Black recipients has closed and that overall survival for all recipients has increased.
The retrospective analysis looked at more than 2,600 adults and children with blood cancers who received cord blood between 2007 and 2017 ...
Nominate a stroke hero today: 2025 Stroke Hero Awards open for submissions
2024-10-01
DALLAS, Oct. 1, 2024 – Strokes can strike at any age, challenging survivors to overcome physical, emotional and cognitive changes. Nominations are open now for the 2025 Stroke Hero Awards from the American Stroke Association, a division of the American Heart Association, which is celebrating a century of lifesaving impact this year. The awards recognize stroke survivors, caregivers, advocates and experts making a difference in the stroke community.
Every 40 seconds someone in the U.S. has a stroke[1], according to the American Heart Association’s 2024 Heart Disease and Stroke Statistical Update. Nearly 1 in 4 stroke survivors face the ...
LAST 30 PRESS RELEASES:
Study unravels another piece of the puzzle in how cancer cells may be targeted by the immune system
Long-sought structure of powerful anticancer natural product solved by integrated approach
World’s oldest lizard wins fossil fight
Simple secret to living a longer life
Same plant, different tactic: Habitat determines response to climate
Drinking plenty of water may actually be good for you
Men at high risk of cardiovascular disease face brain health decline 10 years earlier than women
Irregular sleep-wake cycle linked to heightened risk of major cardiovascular events
Depression can cause period pain, new study suggests
Wistar Institute scientists identify important factor in neural development
New imaging platform developed by Rice researchers revolutionizes 3D visualization of cellular structures
To catch financial rats, a better mousetrap
Mapping the world's climate danger zones
Emory heart team implants new blood-pumping device for first time in U.S.
Congenital heart defects caused by problems with placenta
Schlechter named Cancer Moonshot Scholar
Two-way water transfers can ensure reliability, save money for urban and agricultural users during drought in Western U.S., new study shows
New issue of advances in dental research explores the role of women in dental, clinical, and translational research
Team unlocks new insights on pulsar signals
Great apes visually track subject-object relationships like humans do
Recovery of testing for heart disease risk factors post-COVID remains patchy
Final data and undiscovered images from NASA’s NEOWISE
Nucleoporin93: A silent protector in vascular health
Can we avert the looming food crisis of climate change?
Alcohol use and antiobesity medication treatment
Study reveals cause of common cancer immunotherapy side effect
New era in amphibian biology
Harbor service, VAST Data provide boost for NCSA systems
New prognostic model enhances survival prediction in liver failure
China focuses on improving air quality via the coordinated control of fine particles and ozone
[Press-News.org] St. Jude names M. Madan Babu, PhD, senior vice president and chief data scientistHe will lead new $195 million data science enterprise for biologic discovery to advance pediatric medicine